Barclays raised the firm’s price target on Ceva (CEVA) to $40 from $34 and keeps an Overweight rating on the shares. The company reported 21% year-over-year revenue growth in Q4, higher than the top end of company guidance, the analyst tells investors in a research note. The firm thinks Ceva’s 2025 “looks de-risked” given revenue guidance of 9% at the midpoint.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.